Adial Pharmaceuticals, Inc. Percentage of Weighted Average Cost Inventory
Adial Pharmaceuticals, Inc. (ADIL) had Percentage of Weighted Average Cost Inventory of 44.00% as of 2023-03-31, per its 10-Q filed 2023-05-12.
Discontinued › Notes
us-gaap:PercentageOfWeightedAverageCostInventory · last filed 2023-05-12
- 2023-03-31: Percentage of Weighted Average Cost Inventory 44.00%.
- 2022-12-31: Percentage of Weighted Average Cost Inventory 44.00%.
- 2022-09-30: Percentage of Weighted Average Cost Inventory 44.00%.
- 2022-06-30: Percentage of Weighted Average Cost Inventory 44.00%.
| Period end | Percentage of Weighted Average Cost Inventory |
|---|---|
| 2023-03-31 | 44.00% 10-Q · filed 2023-05-12 |
| 2022-12-31 | 44.00% 10-K · filed 2023-03-30 |
| 2022-09-30 | 44.00% 10-Q · filed 2022-11-14 |
| 2022-06-30 | 44.00% 10-Q · filed 2022-08-15 |
| 2022-03-31 | 45.50% 10-Q · filed 2022-05-16 |
| 2021-12-31 | 43.00% 10-K · filed 2022-03-28 |
| 2021-09-30 | 43.00% 10-Q · filed 2021-11-15 |
| 2021-06-30 | 43.00% 10-Q · filed 2021-08-12 |
| 2021-03-31 | 43.00% 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |